Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Merck KGaA Has Loss on Greek Bonds That Paid for Drugs, FTD Says

Don't Miss Out —
Follow us on:

Sept. 25 (Bloomberg) -- Greek bonds that Merck KGaA received in lieu of payment for drugs delivered to local hospitals lost almost two-thirds of their value, Financial Times Deutschland reported, citing a Merck spokesman. *Merck received bonds worth 55.6 million euros ($72 million) *Bonds covered outstanding bills of 60 million euros incurred between 2007 and 2009 *Greece repaid 12.4 million euros worth of bonds *Merck sold the rest for 8.1 million euros *Bayer AG, Fresenius SE and Biotest AG also took losses on Greek bonds. Link to Company News: MRK GY <Equity> CN <GO>

To contact the reporter on this story: Eva von Schaper in Munich at evonschaper@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.